Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip J Koo

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|July 12, 2021
Novel imaging strategies for prostate cancerPhillip J Koo, Daniel Petrylak
Journal of the American College of Radiology : JACR|October 1, 2013
Nuclear medicine therapy clinics: a golden opportunity for direct longitudinal patient carePhillip J Koo, Brian M Bagrosky
Oncology (Williston Park, N.Y.)|March 5, 2015
¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilizationPhillip J Koo, E David Crawford
Radiology|May 29, 2009
Case 146: Benign multicystic mesotheliomaPhillip J Koo, John S Wills
Nuclear Medicine Communications|July 1, 2014
On noting the achievements and future potential of data-driven gating for respiratory motion correction in PET imagingAdam L Kesner, Phillip J Koo
Current Oncology Reports|January 21, 2022
The Emerging Role of Next-Generation Imaging in Prostate CancerVishnu Murthy, Rahul Aggarwal, Phillip J Koo
Cancer Chemotherapy and Pharmacology|February 20, 2016
Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patientsSeong-Jang Kim, Phillip J Koo, Samuel Chang
Oncology|May 31, 2018
Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-AnalysisHong Ku Ha, Phillip J Koo, Seong-Jang Kim
Journal of Magnetic Resonance Imaging : JMRI|April 24, 2009
MRI features of cellular angiomyofibroma with pathologic correlationPhillip J Koo, Igor Goykhman, Larissa Lembert, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 17, 2016
Estimation of Recurrence Risk After Normal (18)F-FDG PET/CT in Nonsmall-Cell Lung CancerKyoungjune Pak, Seong-Jang Kim, Phillip J Koo, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|July 12, 2021
Novel imaging strategies for prostate cancerPhillip J Koo, Daniel Petrylak
Journal of the American College of Radiology : JACR|October 1, 2013
Nuclear medicine therapy clinics: a golden opportunity for direct longitudinal patient carePhillip J Koo, Brian M Bagrosky
Oncology (Williston Park, N.Y.)|March 5, 2015
¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilizationPhillip J Koo, E David Crawford
Radiology|May 29, 2009
Case 146: Benign multicystic mesotheliomaPhillip J Koo, John S Wills
Nuclear Medicine Communications|July 1, 2014
On noting the achievements and future potential of data-driven gating for respiratory motion correction in PET imagingAdam L Kesner, Phillip J Koo
Current Oncology Reports|January 21, 2022
The Emerging Role of Next-Generation Imaging in Prostate CancerVishnu Murthy, Rahul Aggarwal, Phillip J Koo
Cancer Chemotherapy and Pharmacology|February 20, 2016
Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patientsSeong-Jang Kim, Phillip J Koo, Samuel Chang
Oncology|May 31, 2018
Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-AnalysisHong Ku Ha, Phillip J Koo, Seong-Jang Kim
Journal of Magnetic Resonance Imaging : JMRI|April 24, 2009
MRI features of cellular angiomyofibroma with pathologic correlationPhillip J Koo, Igor Goykhman, Larissa Lembert, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 17, 2016
Estimation of Recurrence Risk After Normal (18)F-FDG PET/CT in Nonsmall-Cell Lung CancerKyoungjune Pak, Seong-Jang Kim, Phillip J Koo, et al.
Pageof 5